Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer

Journal of the National Cancer Institute

Volumn 92, Issue 13, 2000, Pages 1074-1080

  Ranson, Malcolm ^a,h   Davidson, Neville ^b   Nicolson, Marianne ^c   Falk, Stephen ^d   Carmichael, Jim ^e   Lopez, Pedro ^f   Anderson, Heather ^a   Gustafson, Nancy ^g   Jeynes, Allison ^g   Gallant, Giles ^g   Washington, Terri ^g   Thatcher, Nick ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f Northeastern Ontario Regional Cancer Centre   (Canada)

^g BRISTOL MYERS SQUIBB   (United States)

^h CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CORTICOSTEROID; PACLITAXEL;

ADVANCED CANCER; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FOLLOW UP; HUMAN; HYPERSENSITIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT CARE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; WELLBEING;

EID: 0034608773     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.13.1074     Document Type: Article

References (25)

1. Lung cancer: World-wide variation in occurrence and proportion attributable to tobacco use
2. Polychemotherapy in advanced non small cell lung cancer: A meta- analysis
3. Chemotherapy in non-small cell lung cancer a meta-analysis using updated data on individual patients from 52 randomised clinical trials
4. Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature
5. The taxoids: Paclitaxel and docetaxel
6. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions
7. Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer
8. Single-agent paclitaxel in non-small cell lung cancer single-center phase I.I. Study using a 3-hour administration schedule
9. A new international staging system for lung cancer
10. Cancer of the lung
11. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
12. Reporting results of cancer treatment
13. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist
14. Nonparametric estimation from incomplete observation
15. Two-sample asymptotically distribution free tests for incomplete multivariate observations
16. Combining dependent tests with incomplete repeated measurements
17. Pattern mixture models for multivariate incomplete data
18. A class of pattern mixture models for normal incomplete data
19. Modelling the drop out mechanism in repeated measure studies
20. Final report on quality of life and clinical outcomes in advanced non- small cell lung cancer [abstract]
21. Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): Results of a randomized trial in patients with extensive disease
22. Chemotherapy with carboplatin and etoposide improves quality of life and survival in patients with advanced non-small cell lung cancer
23. Relationship between treatment modality and clinical outcomes in NSCLC [abstract]
24. Phase III study of gemcitabine versus best supportive care in advanced non-small cell lung cancer
25. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer